Traws Pharma, Inc. — Director's Dealing 2021

Nov 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2021-11-18

Reporting Person: OLER ABRAHAM N. (SVP Corp Dev & Gen Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-18	Common Stock	X	5000	$3.00	Acquired	17514	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-18	Warrant (right to purchase)	$3.00	X	5000	Disposed	2024-11-25	Common Stock (5000)	Direct

Footnotes

F1: Includes 9,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee.

F2: The warrants were acquired in the November 2019 public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant.